[Carbenicillin-trimethoprim/sulphamethoxazole or carbenicillin-tobramycin as empirical treatment of infection in granulocytopenic patients. A controlled prospective trial (author's transl)].
D000380:Agranulocytosis / Q000150:complications / Q000188:drug therapy; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000150:complications / Q000188:drug therapy; D002228:Carbenicillin / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D006801:Humans; D011446:Prospective Studies; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D014031:Tobramycin / Q000627:therapeutic use*; D014295:Trimethoprim / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D014295:Trimethoprim; D002228:Carbenicillin; D013420:Sulfamethoxazole; D014031:Tobramycin
Carbenicilina-trimetoprim/sulfamethoxazol o carbenicilina-tobramicina como terapéutica empírica de las infecciones en pacientes granulocitopénicos. Estudio prospectivo controlado.